For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome.
Death Receptors and Inflammation
Please visit our Conference calendar for future events’
This event has now passed - please visit our Conference calendar for future Abcam events
A failure of cells to undergo apoptosis is a common feature of many cancers. During the last 20 years, work in many laboratories has led to the identification and understanding of many of the key players involved in apoptosis. This conference will highlight recent developments in our current understanding of the cellular role of some of these proteins as well as how our knowledge of the basic cellular apoptotic pathways is being used to develop targeted cancer chemotherapeutic agents. Particular attention will be paid to novel agents that are currently in development or early clinical trials to exploit our understanding of the Bcl-2 family, the p53 family, death receptors and inhibitor of apoptosis proteins (IAPs). Discussion sessions will involve members from academia as well as industry.
Scientific chair: Prof Gerald Cohen (University of Leicester, UK)
Call 01223 696 000 or contact us